¥4,642.00
0.71% today
Tokyo, Nov 18, 02:15 am CET
ISIN
JP3160400002
Symbol
4523
Index

Eisai Stock price

¥4,675.00
+141.00 3.11% 1M
+879.00 23.16% 6M
+346.00 7.99% YTD
-109.00 2.28% 1Y
-3,924.00 45.63% 3Y
-3,036.00 39.37% 5Y
-3,015.00 39.21% 10Y
+15.00 0.32% 20Y
Tokyo, Closing price Mon, Nov 17 2025
+74.00 1.61%
ISIN
JP3160400002
Symbol
4523
Index
Industry

New AI Insights on Eisai Insights AI Insights on Eisai

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
¥1.3t
Enterprise Value
¥1.2t
Net debt
positive
Cash
¥302.1b
Shares outstanding
282.1m
Valuation (TTM | estimate)
P/E
26.3 | 27.1
P/S
1.6 | 1.6
EV/Sales
1.5 | 1.5
EV/FCF
47.7
P/B
1.5
Dividends
DPS
¥160.00
Yield 1Y | 5Y
3.5% | 2.4%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
97.7% | 95.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
¥804.4b | ¥813.0b
EBITDA
¥100.3b | ¥99.9b
EBIT
¥61.0b | ¥71.2b
Net Income
¥49.4b | ¥47.8b
Free Cash Flow
¥25.2b
Growth (TTM | estimate)
Revenue
6.8% | 3.0%
EBITDA
11.8% | 36.0%
EBIT
22.4% | 43.0%
Net Income
20.5% | 3.0%
Free Cash Flow
250.7%
Margin (TTM | estimate)
Gross
78.3%
EBITDA
12.5% | 12.3%
EBIT
7.6%
Net
6.1% | 5.9%
Free Cash Flow
3.1%
Financial Health
Equity Ratio
60.7%
Return on Equity
5.5%
ROCE
5.8%
ROIC
5.4%
Debt/Equity
0.3
More
EPS
¥175.1
FCF per Share
¥89.4
Short interest
-
Employees
11k
Rev per Employee
¥71.3m
Show more

Is Eisai a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Eisai Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Eisai forecast:

8x Buy
44%
9x Hold
50%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a Eisai forecast:

Buy
44%
Hold
50%
Sell
6%

Financial data from Eisai

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
804,390 804,390
7% 7%
100%
- Direct Costs 174,662 174,662
11% 11%
22%
629,728 629,728
6% 6%
78%
- Selling and Administrative Expenses 415,048 415,048
6% 6%
52%
- Research and Development Expense 165,398 165,398
1% 1%
21%
100,335 100,335
12% 12%
12%
- Depreciation and Amortization 39,376 39,376
1% 1%
5%
EBIT (Operating Income) EBIT 60,959 60,959
22% 22%
8%
Net Profit 49,369 49,369
21% 21%
6%

In millions JPY.

Don't miss a Thing! We will send you all news about Eisai directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Haruo Naito
Employees 11,067
Founded 1936
Website www.eisai.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today